A
ABBV icon

AlphaQuest’s AbbVie ABBV Stock Holding History

AlphaQuest’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-605
Closed -$138K – 8
2025
Q4 		$138K Sell
605
-2,351
-80% -$536K 0.01% 1609
2025
Q3 		$684K Sell
2,956
-5,787
-66% -$1.18M 0.04% 605
2025
Q2 		$1.62M Sell
8,743
-2,413
-22% -$448K 0.16% 140
2025
Q1 		$2.34M Buy
11,156
+10,085
+942% +$1.96M 0.25% 65
2024
Q4 		$190K Sell
1,071
-6,921
-87% -$1.27M 0.03% 878
2024
Q3 		$1.58M Buy
7,992
+7,780
+3,670% +$1.45M 0.14% 207
2024
Q2 		$36.4K Buy
212
+207
+4,140% +$34.3K ﹤0.01% 1184
2024
Q1 		$911 Buy
5
+4
+400% +$689 ﹤0.01% 1434
2023
Q4 		$155 Buy
+1
New +$146 ﹤0.01% 1041

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AlphaQuest's ABBV Position: Q1 2026 in Review

AlphaQuest sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 605 shares — an estimated $138K sold.

AlphaQuest first reported a position in ABBV in Q4 2023 and held it in 9 quarters. The position peaked at $2.34M in Q1 2025. 4,097 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • AlphaQuest reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 605 AbbVie shares in Q1 2026, an estimated $138K.
  • AlphaQuest first reported a position in AbbVie in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's AbbVie position peaked at $2.34M in Q1 2025.
  • 4,097 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.